Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 309

    1.

    Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

    Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME.

    Ann Intern Med. 1999 Mar 16;130(6):478-86.PMID: 10075615 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Etanercept: a review of its use in rheumatoid arthritis.

    Jarvis B, Faulds D.

    Drugs. 1999 Jun;57(6):945-66. Review.PMID: 10400407 [PubMed - indexed for MEDLINE]Related articles

    3.

    Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

    Culy CR, Keating GM.

    Drugs. 2002;62(17):2493-537. Review.PMID: 12421111 [PubMed - indexed for MEDLINE]Related articles

    4.

    A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.

    N Engl J Med. 1999 Jan 28;340(4):253-9.PMID: 9920948 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.

    Lan JL, Chou SJ, Chen DY, Chen YH, Hsieh TY, Young M Jr.

    J Formos Med Assoc. 2004 Aug;103(8):618-23.PMID: 15340661 [PubMed - indexed for MEDLINE]Related articles

    6.

    Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

    Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

    Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.PMID: 16948890 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

    Culy CR, Keating GM.

    BioDrugs. 2003;17(2):139-45. Review.PMID: 12641492 [PubMed - indexed for MEDLINE]Related articles

    8.

    Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

    Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ.

    Arthritis Rheum. 2004 Feb;50(2):353-63.PMID: 14872476 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

    Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martín Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M; TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators.

    Lancet. 2004 Feb 28;363(9410):675-81.PMID: 15001324 [PubMed - indexed for MEDLINE]Related articles

    10.

    Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.

    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.

    Arthritis Rheum. 2003 Jun;48(6):1493-9.PMID: 12794815 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.

    Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK.

    Clin Ther. 2003 Jun;25(6):1700-21.PMID: 12860493 [PubMed - indexed for MEDLINE]Related articles

    12.

    Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison.

    Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Wajdula J, Fatenejad S; Etanercept European Investigators Network (Etanercept Study 309 Investigators).

    Ann Rheum Dis. 2006 Oct;65(10):1357-62. Epub 2006 Apr 10.PMID: 16606651 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.

    Weinblatt M, Schiff M, Goldman A, Kremer J, Luggen M, Li T, Chen D, Becker JC.

    Ann Rheum Dis. 2007 Feb;66(2):228-34. Epub 2006 Aug 25.PMID: 16935912 [PubMed - indexed for MEDLINE]Related articles

    14.

    Etanercept for the treatment of rheumatoid arthritis.

    Blumenauer B, Judd M, Cranney A, Burls A, Coyle D, Hochberg M, Tugwell P, Wells G.

    Cochrane Database Syst Rev. 2003;(4):CD004525. Review.PMID: 14584021 [PubMed - indexed for MEDLINE]Related articles

    15.

    Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.

    Gorman JD, Sack KE, Davis JC Jr.

    N Engl J Med. 2002 May 2;346(18):1349-56.PMID: 11986408 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

    Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM.

    N Engl J Med. 1997 Jul 17;337(3):141-7.PMID: 9219699 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

    Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

    Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.PMID: 17049139 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.

    Schiff MH, Yu EB, Weinblatt ME, Moreland LW, Genovese MC, White B, Singh A, Chon Y, Woolley JM.

    Drugs Aging. 2006;23(2):167-78.PMID: 16536638 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

    Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Li T, Ge Z, Becker JC, Westhovens R.

    Ann Intern Med. 2006 Jun 20;144(12):865-76.PMID: 16785475 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

    Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I.

    Arch Intern Med. 1999 Nov 22;159(21):2542-50.PMID: 10573044 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data